BIIB vs HSY · P/E 21, rev $9.89B vs P/E 36, rev $5.89B
Biogen Inc (BIIB) versus Hershey Co (HSY) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Hershey Co (HSY) is a confectioners company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported HSY revenue for 2026-06-28 was $5.89B. Net income was $892.8M. Revenue was up 89.8% from 2026-03-29 to 2026-06-28. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
Not investment advice. Open the BIIB and HSY stock pages for the full models.
Not investment advice.